These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis. Bilgic H; Ytterberg SR; Amin S; McNallan KT; Wilson JC; Koeuth T; Ellingson S; Newman B; Bauer JW; Peterson EJ; Baechler EC; Reed AM Arthritis Rheum; 2009 Nov; 60(11):3436-46. PubMed ID: 19877033 [TBL] [Abstract][Full Text] [Related]
4. Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab. Aggarwal R; Oddis CV; Goudeau D; Koontz D; Qi Z; Reed AM; Ascherman DP; Levesque MC Rheumatology (Oxford); 2016 Jun; 55(6):991-9. PubMed ID: 26888854 [TBL] [Abstract][Full Text] [Related]
5. Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up. Zong M; Dorph C; Dastmalchi M; Alexanderson H; Pieper J; Amoudruz P; Barbasso Helmers S; Nennesmo I; Malmström V; Lundberg IE Ann Rheum Dis; 2014 May; 73(5):913-20. PubMed ID: 23625983 [TBL] [Abstract][Full Text] [Related]
6. Rituximab as an effective alternative therapy in refractory idiopathic inflammatory myopathies. Muñoz-Beamud F; Isenberg DA Clin Exp Rheumatol; 2013; 31(6):896-903. PubMed ID: 24050676 [TBL] [Abstract][Full Text] [Related]
7. Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial. Rider LG; Yip AL; Horkayne-Szakaly I; Volochayev R; Shrader JA; Turner ML; Kong HH; Jain MS; Jansen AV; Oddis CV; Fleisher TA; Miller FW Clin Exp Rheumatol; 2014; 32(5):689-96. PubMed ID: 25068290 [TBL] [Abstract][Full Text] [Related]
8. Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis. Rismo R; Olsen T; Cui G; Christiansen I; Florholmen J; Goll R Scand J Gastroenterol; 2012 May; 47(5):538-47. PubMed ID: 22486187 [TBL] [Abstract][Full Text] [Related]
9. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672 [TBL] [Abstract][Full Text] [Related]
10. Muscle myeloid type I interferon gene expression may predict therapeutic responses to rituximab in myositis patients. Nagaraju K; Ghimbovschi S; Rayavarapu S; Phadke A; Rider LG; Hoffman EP; Miller FW Rheumatology (Oxford); 2016 Sep; 55(9):1673-80. PubMed ID: 27215813 [TBL] [Abstract][Full Text] [Related]
11. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Wong CK; Lam CW; Wu AK; Ip WK; Lee NL; Chan IH; Lit LC; Hui DS; Chan MH; Chung SS; Sung JJ Clin Exp Immunol; 2004 Apr; 136(1):95-103. PubMed ID: 15030519 [TBL] [Abstract][Full Text] [Related]
12. Th1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris. Timoteo RP; da Silva MV; Miguel CB; Silva DA; Catarino JD; Rodrigues Junior V; Sales-Campos H; Freire Oliveira CJ Mediators Inflamm; 2017; 2017():7151285. PubMed ID: 28321152 [TBL] [Abstract][Full Text] [Related]
14. C-C chemokines differentially alter interleukin-4 production from lymphocytes. Lukacs NW; Chensue SW; Karpus WJ; Lincoln P; Keefer C; Strieter RM; Kunkel SL Am J Pathol; 1997 May; 150(5):1861-8. PubMed ID: 9137108 [TBL] [Abstract][Full Text] [Related]
15. B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab. Rosenzwajg M; Languille E; Debiec H; Hygino J; Dahan K; Simon T; Klatzmann D; Ronco P Kidney Int; 2017 Jul; 92(1):227-237. PubMed ID: 28318628 [TBL] [Abstract][Full Text] [Related]
16. A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Tiringer K; Treis A; Fucik P; Gona M; Gruber S; Renner S; Dehlink E; Nachbaur E; Horak F; Jaksch P; Döring G; Crameri R; Jung A; Rochat MK; Hörmann M; Spittler A; Klepetko W; Akdis CA; Szépfalusi Z; Frischer T; Eiwegger T Am J Respir Crit Care Med; 2013 Mar; 187(6):621-9. PubMed ID: 23306544 [TBL] [Abstract][Full Text] [Related]
17. Serum Th1/Th2 and macrophage lineage cytokines in leprosy; correlation with circulating CD4(+) CD25(high) FoxP3(+) T-regs cells. Abdallah M; Attia EA; Saad AA; El-Khateeb EA; Lotfi RA; Abdallah M; El-Shennawy D Exp Dermatol; 2014 Oct; 23(10):742-7. PubMed ID: 25109693 [TBL] [Abstract][Full Text] [Related]